Results 161 to 170 of about 47,640 (336)

Field Programmable Gate Arrays with Hardwired Networks on Chip

open access: yes, 2012
Technology down-scaling and platform-based designs have enforced a number of application and architecture trends for system-on-chip (SOC) designs. A modern SOC is now a multi-functional machine that can execute a large number of complex applications by using tens or even hundreds of intellectual properties (IPs).
openaire   +3 more sources

Integrating Spatial Proteogenomics in Cancer Research

open access: yesAdvanced Science, EarlyView.
Xx xx. ABSTRACT Background: Spatial proteogenomics marks a paradigm shift in oncology by integrating molecular analysis with spatial information from both spatial proteomics and other data modalities (e.g., spatial transcriptomics), thereby unveiling tumor heterogeneity and dynamic changes in the microenvironment.
Yida Wang   +13 more
wiley   +1 more source

Secure Configuration of Field Programmable Gate Arrays

open access: yes, 2001
Although SRAM programmed Field Programmable Gate Arrays (FPGA's) have come to dominate the industry due to their density and performance advantages over non-volatile technologies they have a serious weakness in that they are vulnerable to piracy and reverse engineering of the user design.
openaire   +1 more source

Liquid Metal Nanotransformers for Drug‐Resistant Pan‐Cancer Therapy in Patient‐Derived Organoids

open access: yesAdvanced Science, EarlyView.
Pan‐cancer therapies are severely limited in drug‐resistance patients due to genetic mutations and other factors, resulting in poor therapeutic outcomes and constrained clinical benefit. Liquid metal nanotransformers, a new class of shape‐transformable nanomaterials capable of dramatic morphological changes, offer a promising physical strategy to ...
Xiaojie Yuan   +19 more
wiley   +1 more source

Selective Targeting of Immune Checkpoints HLA‐G and CD47 Using Novel Dual Signaling Protein DSP216 Promotes Innate Anticancer Immunity

open access: yesAdvanced Science, EarlyView.
The inhibitory immune checkpoints HLA‐G and CD47 are expressed on certain tumor types and inhibit immune cells in the tumor microenvironment. DSP216 binds specifically to cancer cells expressing both HLA‐G and CD47, and blocks their inhibitory signaling.
Lisa J. Jacob   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy